Galaxy G3
Device Neurosurgery
PDI 10886704080275
General payments
$4,195
Research payments
$977,026
Through program year 2025, $4,195 in general payments and $977,026 in research payments were reported against Galaxy G3 (Neurosurgery).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $73 | 2 |
| 2025 | Research | $106,368 | 63 |
| 2024 | General | $9 | 1 |
| 2024 | Research | $127,084 | 84 |
| 2023 | General | $529 | 17 |
| 2023 | Research | $228,487 | 142 |
| 2022 | General | $906 | 27 |
| 2022 | Research | $206,801 | 135 |
| 2021 | General | $2,678 | 44 |
| 2021 | Research | $308,286 | 162 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
91 general · 586 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.